argenx SE (ARGX)

CTI BioPharma Revenue

argenx SE had revenue of $967.19M in the quarter ending June 30, 2025, with 97.62% growth. This brings the company's revenue in the last twelve months to $3.12B, up 88.04% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.

• Revenue (ttm): $3.12B
• Revenue Growth: +88.04%
• P/S Ratio: 13.33
• Revenue / Employee: $1,951,733
• Employees: 1,599
• Market Cap: 41.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.25B	979.61M	77.22%
Dec 31, 2023	1.27B	827.58M	187.66%
Dec 31, 2022	441.01M	-87.25M	-16.52%
Dec 31, 2021	528.27M	466.31M	752.59%
Dec 31, 2020	61.96M	-30.85M	-33.24%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.